Walgreens Boots Alliance (NASDAQ:WBA) Given New $50.00 Price Target at Cowen

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) had its price objective trimmed by Cowen from $55.00 to $50.00 in a report published on Tuesday morning, The Fly reports.

A number of other equities analysts have also issued reports on the stock. UBS Group decreased their target price on shares of Walgreens Boots Alliance from $52.00 to $49.00 and set a neutral rating for the company in a research report on Tuesday, April 5th. Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $58.00 to $50.00 and set a hold rating for the company in a research report on Friday, April 1st. Robert W. Baird lowered shares of Walgreens Boots Alliance from an outperform rating to a neutral rating and decreased their target price for the company from $70.00 to $51.00 in a research report on Friday, April 1st. Morgan Stanley lowered shares of Walgreens Boots Alliance from an equal weight rating to an underweight rating and decreased their target price for the company from $56.00 to $49.00 in a research report on Thursday, December 16th. Finally, Mizuho upped their price target on shares of Walgreens Boots Alliance from $51.00 to $56.00 in a report on Monday, January 10th. One research analyst has rated the stock with a sell rating and twelve have assigned a hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of Hold and a consensus price target of $50.71.

Walgreens Boots Alliance stock opened at $44.23 on Tuesday. The company has a 50-day simple moving average of $46.88 and a 200-day simple moving average of $48.54. The firm has a market capitalization of $38.20 billion, a P/E ratio of 6.10, a P/E/G ratio of 2.48 and a beta of 0.55. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.35 and a current ratio of 0.74. Walgreens Boots Alliance has a one year low of $42.90 and a one year high of $55.96.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last released its quarterly earnings results on Thursday, March 31st. The pharmacy operator reported $1.59 EPS for the quarter, topping the consensus estimate of $1.40 by $0.19. The business had revenue of $33.76 billion during the quarter, compared to analyst estimates of $33.33 billion. Walgreens Boots Alliance had a net margin of 4.62% and a return on equity of 19.15%. The company’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.40 earnings per share. As a group, sell-side analysts forecast that Walgreens Boots Alliance will post 5.05 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 11th. Shareholders of record on Friday, February 18th were paid a dividend of $0.48 per share. The ex-dividend date of this dividend was Thursday, February 17th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. This represents a $1.92 dividend on an annualized basis and a yield of 4.34%. Walgreens Boots Alliance’s dividend payout ratio is currently 26.34%.

A number of hedge funds have recently bought and sold shares of the business. Investors Financial Group LLC lifted its position in Walgreens Boots Alliance by 2.7% in the fourth quarter. Investors Financial Group LLC now owns 7,092 shares of the pharmacy operator’s stock worth $370,000 after purchasing an additional 189 shares during the period. Veriti Management LLC lifted its position in Walgreens Boots Alliance by 1.5% in the fourth quarter. Veriti Management LLC now owns 13,534 shares of the pharmacy operator’s stock worth $706,000 after purchasing an additional 197 shares during the period. Bangor Savings Bank lifted its position in Walgreens Boots Alliance by 0.6% in the fourth quarter. Bangor Savings Bank now owns 31,213 shares of the pharmacy operator’s stock worth $1,628,000 after purchasing an additional 197 shares during the period. Carlton Hofferkamp & Jenks Wealth Management LLC lifted its position in Walgreens Boots Alliance by 1.0% in the fourth quarter. Carlton Hofferkamp & Jenks Wealth Management LLC now owns 19,989 shares of the pharmacy operator’s stock worth $1,019,000 after purchasing an additional 200 shares during the period. Finally, Centerpoint Advisors LLC lifted its position in Walgreens Boots Alliance by 20.7% in the fourth quarter. Centerpoint Advisors LLC now owns 1,190 shares of the pharmacy operator’s stock worth $62,000 after purchasing an additional 204 shares during the period. 56.05% of the stock is owned by institutional investors.

Walgreens Boots Alliance Company Profile (Get Rating)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

See Also

The Fly logo

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.